| 1 |
Wang B, Gan Q, Tong Y, Qiao Y, Han M, Zhang R, Han Q, Li C, Bai S, Xu L, Yin Y, Zhang C, Munkhtsetseg B, Zhao X, Meng M, Xi R. A visual diagnostic detection of Helicobacter pylori and the gastric carcinoma-related virulence genes (cagA and vacA) by a fluorescent loop-mediated isothermal amplification (LAMP). Talanta 2023;256:124260. [PMID: 36640706 DOI: 10.1016/j.talanta.2023.124260] [Reference Citation Analysis]
|
| 2 |
Bucci P, Barbaglia Y, Tedeschi F, Zalazar F. Helicobacter pylori infection: A balance between bacteria and host. Rev Argent Microbiol 2023;55:60-7. [PMID: 35773060 DOI: 10.1016/j.ram.2022.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Tamjid N, Eskandari S, Karimi Z, Nezafat N, Negahdaripour M. Vaccinomics strategy to design an epitope peptide vaccine against Helicobacter pylori. Process Biochemistry 2022;121:380-95. [DOI: 10.1016/j.procbio.2022.07.007] [Reference Citation Analysis]
|
| 4 |
Majewski M, Mertowska P, Mertowski S, Smolak K, Grywalska E, Torres K. Microbiota and the Immune System-Actors in the Gastric Cancer Story. Cancers (Basel) 2022;14:3832. [PMID: 35954495 DOI: 10.3390/cancers14153832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Wu L, Jiang F, Shen X. Helicobacter pylori CagA Protein Regulating the Biological Characteristics of Gastric Cancer through the miR-155-5p/SMAD2/SP1 axis. Pathogens 2022;11:846. [DOI: 10.3390/pathogens11080846] [Reference Citation Analysis]
|
| 6 |
Tsukanov VV, Smirnova OV, Kasparov EV, Sinyakov AA, Vasyutin AV, Tonkikh JL, Cherepnin MA. Dynamics of Oxidative Stress in Helicobacter pylori-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer. Diagnostics 2022;12:1203. [DOI: 10.3390/diagnostics12051203] [Reference Citation Analysis]
|
| 7 |
Yang Y, Huang Y, Lin W, Liu J, Chen X, Chen C, Yu X, Teng L. Host miRNAs-microbiota interactions in gastric cancer. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03264-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Araújo GRL, Marques HS, Santos MLC, da Silva FAF, da Brito BB, Correa Santos GL, de Melo FF. Helicobacter pylori infection: How does age influence the inflammatory pattern? World J Gastroenterol 2022; 28(4): 402-411 [DOI: 10.3748/wjg.v28.i4.402] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Pontes JC, Pontes JC, Silva LLDL, Moraes Filho AVD, Bitencourt CA, Itria A, Carneiro LC, Barbosa MS. Spending Estimates for Gastric Cancer in Central Brazil. Braz J Pharm Sci 2022;58:e181069. [DOI: 10.1590/s2175-97902022e181069] [Reference Citation Analysis]
|
| 10 |
Zhao G, Zhang Z, Li B, Huang S, Li W, Zhu C, Jiang B, He S, Wang Y, Wang S. Follow-up analysis and histopathological study of gastric mucosa in patients with Helicobacter pylori infection. J Int Med Res 2021;49:030006052110553. [DOI: 10.1177/03000605211055397] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 11 |
Oliveira AKS, Silva LLL, Miguel MP, Blanco AJV, Carneiro LC, Barbosa MS. HELICOBACTER PYLORI cagA VIRULENCE GENE AND SEVERE ESOGASTRODUODENAL DISEASES: IS THERE AN ASSOCIATION? Arq Gastroenterol 2021;58:468-75. [PMID: 34909852 DOI: 10.1590/S0004-2803.202100000-85] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Trivanović D, Pavelić K, Peršurić Ž. Fighting Cancer with Bacteria and Their Toxins. Int J Mol Sci 2021;22:12980. [PMID: 34884780 DOI: 10.3390/ijms222312980] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Muthusamy S, Jan HM, Hsieh MY, Mondal S, Liu WC, Ko YA, Yang WY, Mong KT, Chen GC, Lin CH. Enhanced enzymatic production of cholesteryl 6'-acylglucoside impairs lysosomal degradation for the intracellular survival of Helicobacter pylori. J Biomed Sci 2021;28:72. [PMID: 34706729 DOI: 10.1186/s12929-021-00768-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 14 |
de Lima Silva LL, Oliveira AKS, Gama AR, Ramos AFPL, Silva AMTC, Blanco AJV, Vieira JDG, Rasmussem LT, Carneiro LC, Barbosa MS. Helicobacter pylori virulence dupA gene: risk factor or protective factor? Braz J Microbiol 2021. [PMID: 34255308 DOI: 10.1007/s42770-021-00553-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Pourfarzi F, Zahirian Moghadam T, Zandian H, Malekzadeh R, Yazdanbod A. Cost-effectiveness analysis of two routine therapeutic methods for Helicobacter pylori eradication: a Persian cohort-based study. Gastroenterol Hepatol Bed Bench 2021;14:250-9. [PMID: 34221265] [Reference Citation Analysis]
|
| 16 |
Jia J, Zhang C, Liu Y, Huang Y, Bai Y, Hang X, Zeng L, Zhu D, Bi H. Armeniaspirol A: a novel anti-Helicobacter pylori agent. Microb Biotechnol 2021. [PMID: 33780131 DOI: 10.1111/1751-7915.13807] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 17 |
Dhameja N, Yadav D, Shukla S, Dixit V. Precursor lesions of gastric carcinoma: A histopathological study. Int J Clinicopathol Correl 2021;5:49. [DOI: 10.4103/ijcpc.ijcpc_16_20] [Reference Citation Analysis]
|
| 18 |
Kim HS, Yoon H, Shin DW, Oh DJ, Kwon M, Choi YJ, Shin CM, Park YS, Kim N, Lee DH. Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Helicobacter pylori Eradication. Korean J Helicobacter Up Gastrointest Res 2020;20:218-224. [DOI: 10.7704/kjhugr.2020.0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 19 |
Szymczak A, Ferenc S, Majewska J, Miernikiewicz P, Gnus J, Witkiewicz W, Dąbrowska K. Application of 16S rRNA gene sequencing in Helicobacter pylori detection. PeerJ 2020;8:e9099. [PMID: 32440373 DOI: 10.7717/peerj.9099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 21 |
Woo HJ, Yang JY, Lee MH, Kim HW, Kwon HJ, Park M, Kim SK, Park SY, Kim SH, Kim JB. Inhibitory Effects of β-Caryophyllene on Helicobacter pylori Infection In Vitro and In Vivo. Int J Mol Sci 2020;21:E1008. [PMID: 32028744 DOI: 10.3390/ijms21031008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 22 |
Das S, Kundu M, Jena BC, Mandal M. Causes of cancer: physical, chemical, biological carcinogens, and viruses. Biomaterials for 3D Tumor Modeling 2020. [DOI: 10.1016/b978-0-12-818128-7.00025-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 23 |
Rodrigues MF, Guerra MR, Alvarenga AVRD, Souza DZDO, Costa RAVES, Cupolilo SMN. HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER PRECURSOR LESIONS: PREVALENCE AND ASSOCIATED FACTORS IN A REFERENCE LABORATORY IN SOUTHEASTERN BRAZIL. Arq Gastroenterol 2019;56:419-424. [DOI: 10.1590/s0004-2803.201900000-84] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 24 |
Ahmad AA, Kasim KF, Ma’radzi AH, Gopinath SC. Peptic ulcer: Current prospects of diagnostic and nanobiotechnological trends on pathogenicity. Process Biochemistry 2019;85:51-9. [DOI: 10.1016/j.procbio.2019.06.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 25 |
Borges SS, Ramos AFPL, Moraes Filho AV, Braga CADSB, Carneiro LC, Barbosa MS. [ARTICLE PARTIAL RETRACTION] PREVALENCE OF HELICOBACTER PYLORI INFECTION IN DYSPEPTIC PATIENTS AND ITS ASSOCIATION WITH CLINICAL RISK FACTORS FOR DEVELOPING GASTRIC ADENOCARCINOMA. Arq Gastroenterol 2019;56:66-70. [PMID: 31141074 DOI: 10.1590/S0004-2803.201900000-03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 26 |
Mohamed WA, Schaalan MF, Ramadan B. The expression profiling of circulating miR-204, miR-182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer. J Cell Biochem. 2019;120:13464-13477. [PMID: 30945348 DOI: 10.1002/jcb.28620] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
Zhou C, Pan R, Li B, Huang T, Zhao J, Ying J, Duan S. GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60. Future Oncol 2019;15:1279-89. [PMID: 30924352 DOI: 10.2217/fon-2018-0674] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 28 |
Kebudi R, Kiykim A, Sahin MK. Primary Immunodeficiency and Cancer in Children; A Review of the Literature. Curr Pediatr Rev 2019;15:245-50. [PMID: 31530267 DOI: 10.2174/1573396315666190917154058] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 29 |
Louise Møller Nordestgaard R, Roed Spiegelhauer M, Havnhøj Frandsen T, Gren C, Tving Stauning A, Percival Andersen L. Clinical Manifestations of the Epsilonproteobacteria (Helicobacter pylori). Helicobacter pylori [Working Title] 2018. [DOI: 10.5772/intechopen.80331] [Reference Citation Analysis]
|
| 30 |
Bruno G, Rocco G, Zaccari P, Porowska B, Mascellino MT, Severi C. Helicobacter pylori Infection and Gastric Dysbiosis: Can Probiotics Administration Be Useful to Treat This Condition? Can J Infect Dis Med Microbiol. 2018;2018:6237239. [PMID: 30275917 DOI: 10.1155/2018/6237239] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 31 |
Pucułek M, Machlowska J, Wierzbicki R, Baj J, Maciejewski R, Sitarz R. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype. Oncotarget 2018;9:31146-62. [PMID: 30123433 DOI: 10.18632/oncotarget.25757] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 32 |
Tsukanov VV, Smirnova OV, Kasparov EV, Sinyakov AA, Vasyutin AV, Tonkikh YL. Changes in the indices of prooxidant and antioxidant systems in blood plasma in men with atrophic gastritis and gastric cancer. Ter Arkh 2018;90:24-7. [PMID: 30701768 DOI: 10.26442/terarkh201890224-27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 33 |
Hodge CD, Spyracopoulos L, Glover JN. Ubc13: the Lys63 ubiquitin chain building machine. Oncotarget 2016;7:64471-504. [PMID: 27486774 DOI: 10.18632/oncotarget.10948] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 34 |
Liu Z, Shi Y, Na Y, Zhang Q, Cao S, Duan X, Zhang X, Yang H, Jin T, Li Y. Genetic polymorphisms in TNIP1 increase the risk of gastric carcinoma. Oncotarget 2016;7:40500-7. [PMID: 27250029 DOI: 10.18632/oncotarget.9637] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 35 |
Overbey DM, Jones EL. Acid Peptic Ulcer Disease. Abernathy's Surgical Secrets 2018. [DOI: 10.1016/b978-0-323-47873-1.00047-4] [Reference Citation Analysis]
|
| 36 |
Yang YJ, Wu CT, Ou HY, Lin CH, Cheng HC, Chang WL, Chen WY, Yang HB, Lu CC, Sheu BS. Male non-insulin users with type 2 diabetes mellitus are predisposed to gastric corpus-predominant inflammation after H. pylori infection. J Biomed Sci 2017;24:82. [PMID: 29082856 DOI: 10.1186/s12929-017-0389-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 37 |
Shao Y, Lu R, Yang Y, Xu Q, Wang B, Ye G. Antibiotic resistance of Helicobacter pylori to 16 antibiotics in clinical patients. J Clin Lab Anal. 2018;32:e22339. [PMID: 28984385 DOI: 10.1002/jcla.22339] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 38 |
Zabala Torrres B, Lucero Y, Lagomarcino AJ, Orellana-Manzano A, George S, Torres JP, O'Ryan M. Review: Prevalence and dynamics of Helicobacter pylori infection during childhood. Helicobacter 2017;22. [PMID: 28643393 DOI: 10.1111/hel.12399] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 39 |
Yang YJ, Wu CT, Ou HY, Lin CH, Cheng HC, Chang WL, Chen WY, Yang HB, Lu CC, Sheu BS. Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes. Ann Med 2017;49:479-86. [PMID: 28266875 DOI: 10.1080/07853890.2017.1294761] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Paredes-Osses E, Sáez K, Sanhueza E, Hebel S, González C, Briceño C, García Cancino A. Association between cagA, vacAi, and dupA genes of Helicobacter pylori and gastroduodenal pathologies in Chilean patients. Folia Microbiol (Praha) 2017;62:437-44. [PMID: 28283946 DOI: 10.1007/s12223-017-0514-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 41 |
Trindade LM, Menezes LB, de Souza Neta AM, Leite Rolemberg PC, Souza LD, Barreto ID, Meurer L. Prevalence of Helicobacter pylori Infection in Samples of Gastric Biopsies. Gastroenterology Res 2017;10:33-41. [PMID: 28270875 DOI: 10.14740/gr785w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 42 |
Xu Q, Chen TJ, He CY, Sun LP, Liu JW, Yuan Y. MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori. Sci Rep 2017;7:41307. [PMID: 28150722 DOI: 10.1038/srep41307] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 43 |
Kato M, Nishihara H, Hayashi H, Kimura T, Ishida Y, Wang L, Tsuda M, Tanino MA, Tanaka S. Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma. Med Oncol 2017;34. [DOI: 10.1007/s12032-016-0865-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 44 |
Zhang R, Peng X, Duan G, Shi Q, Chen S, Wang C, Fan Q, Xi Y. An engineered Lactococcus lactis strain exerts significant immune responses through efficient expression and delivery of Helicobacter pylori Lpp20 antigen. Biotechnol Lett 2016;38:2169-75. [PMID: 27646988 DOI: 10.1007/s10529-016-2209-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
